Cargando…

Bench to Bedside: Stability Studies of GMP Produced Trastuzumab-TCMC in Support of a Clinical Trial

The first-in-human phase 1 clinical radioimmunotherapy (RIT) trial with (212)Pb-1,4,7,10-tetraaza-1,4,7,10-tetra-(2-carbamoylmethyl)-cyclododecane-trastuzumab ((212)Pb-TCMC-trastuzumab) was completed in October 2014 as a joint effort at the University of Alabama (UAB) and the University of Californi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Milenic, Diane E., Baidoo, Kwamena E., Brechbiel, Martin W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4588176/ https://www.ncbi.nlm.nih.gov/pubmed/26230702 http://dx.doi.org/10.3390/ph8030435

Ejemplares similares

Gene expression profiling upon (212)Pb-TCMC-trastuzumab treatment in the LS-174T i.p. xenograft model
por: Yong, Kwon J, et al.
Publicado: (2013)

Cell Killing Mechanisms and Impact on Gene Expression by Gemcitabine and (212)Pb-Trastuzumab Treatment in a Disseminated i.p. Tumor Model
por: Yong, Kwon Joong, et al.
Publicado: (2016)

Pre-Clinical Assessment of (177)Lu-Labeled Trastuzumab Targeting HER2 for Treatment and Management of Cancer Patients with Disseminated Intraperitoneal Disease
por: Ray, Geoffrey L., et al.
Publicado: (2011)

Impact of α-Targeted Radiation Therapy on Gene Expression in a Pre-Clinical Model for Disseminated Peritoneal Disease when Combined with Paclitaxel
por: Yong, Kwon Joong, et al.
Publicado: (2014)

Mechanisms of Cell Killing Response from Low Linear Energy Transfer (LET) Radiation Originating from (177)Lu Radioimmunotherapy Targeting Disseminated Intraperitoneal Tumor Xenografts
por: Yong, Kwon Joong, et al.
Publicado: (2016)

HER1-Targeted (86)Y-Panitumumab Possesses Superior Targeting Characteristics than (86)Y-Cetuximab for PET Imaging of Human Malignant Mesothelioma Tumors Xenografts
por: Nayak, Tapan K., et al.
Publicado: (2011)

In Vitro and In Vivo Analysis of Indocyanine Green-Labeled Panitumumab for Optical Imaging—A Cautionary Tale
por: Zhou, Yang, et al.
Publicado: (2014)

Targeted α-Particle Radiation Therapy of HER1-Positive Disseminated Intraperitoneal Disease: An Investigation of the Human Anti-EGFR Monoclonal Antibody, Panitumumab
por: Milenic, Diane E., et al.
Publicado: (2017)

Toxicological Studies of (212)Pb Intravenously or Intraperitoneally Injected into Mice for a Phase 1 Trial
por: Milenic, Diane E., et al.
Publicado: (2015)

In vitro and in vivo pre-clinical analysis of a F(ab')(2 )fragment of panitumumab for molecular imaging and therapy of HER1-positive cancers
por: Wong, Karen J, et al.
Publicado: (2011)

Safety and Outcome Measures of First-in-Human Intraperitoneal α Radioimmunotherapy With (212)Pb-TCMC-Trastuzumab
por: Meredith, Ruby F., et al.
Publicado: (2018)

(212)Pb-radioimmunotherapy potentiates paclitaxel-induced cell killing efficacy by perturbing the mitotic spindle checkpoint
por: Yong, K J, et al.
Publicado: (2013)

Takotsubo Syndrome: From Bench to Bedside and Bedside to Bench
por: Pelliccia, Francesco, et al.
Publicado: (2022)

Bench and Bedside
por: Schmidt, Christian
Publicado: (2002)

From bench to bedside
por: Verdant, Colin L
Publicado: (2012)

Neuroimaging in Psychiatry: From Bench to Bedside
por: Linden, David E. J., et al.
Publicado: (2009)

Sepsis: From Bench to Bedside
por: Silva, Eliézer, et al.
Publicado: (2008)

Sonochemotherapy: from bench to bedside
por: Lammertink, Bart H. A., et al.
Publicado: (2015)

Nutrition: From Bench to Bedside
por: Khan, Naim A., et al.
Publicado: (2016)

Linagliptin: from bench to bedside
por: Doupis, John
Publicado: (2014)

Pruritus: From the Bench to the Bedside
por: Reich, Adam, et al.
Publicado: (2018)

Silver linings at the bench and bedside
por: Katz, Steven C., et al.
Publicado: (2020)

Olutasidenib: from bench to bedside
por: Venugopal, Sangeetha, et al.
Publicado: (2023)

HIF stabilizers in the management of renal anemia: from bench to bedside to pediatrics
por: Kular, Dalvir, et al.
Publicado: (2018)

Bench-To-Bedside and Bedside Back to the Bench; Coordinating Clinical and Experimental Traumatic Brain Injury Studies
por: Agoston, Denes V., et al.
Publicado: (2012)

Bench-to-bedside review: Recruitment and recruiting maneuvers
por: Lapinsky, Stephen E, et al.
Publicado: (2005)

Bench-to-bedside review: Rhabdomyolysis – an overview for clinicians
por: Huerta-Alardín, Ana L, et al.
Publicado: (2005)

Bench-to-bedside review: An approach to hemodynamic monitoring - Guyton at the bedside
por: Magder, Sheldon
Publicado: (2012)

Research in Sickle Cell Disease: From Bedside to Bench to Bedside
por: Salinas Cisneros, Gabriel, et al.
Publicado: (2021)

Inositol(s) from Bench to Bedside in Endocrinology and Gynecology
por: Unfer, Vittorio, et al.
Publicado: (2017)

Editorial: Cardio-Oncology: From Bench to Bedside
por: Abe, Jun-ichi, et al.
Publicado: (2019)

RTK Inhibitors in Melanoma: From Bench to Bedside
por: Sabbah, Malak, et al.
Publicado: (2021)

Micrornas and Cardiovascular Diseases: From Bench to Bedside
por: De Rosa, R., et al.
Publicado: (2018)

From (Tool)Bench to Bedside: The Potential of Necroptosis Inhibitors
por: Gardner, Christopher R., et al.
Publicado: (2023)

Cancer proteomics: from bench to bedside
por: Timms, J F
Publicado: (2008)

Bench-to-bedside review: Metabolism and nutrition
por: Casaer, Michaël P, et al.
Publicado: (2008)

Bench-to-bedside review: Permissive hypercapnia
por: O' Croinin, Donall, et al.
Publicado: (2005)

DNA sequencing: bench to bedside and beyond(†)
por: Hutchison, Clyde A.
Publicado: (2007)

The hantaviruses of Europe: from the bedside to the bench.
por: Clement, J, et al.
Publicado: (1997)

RECENT ADVANCES IN PSORIASIS: BENCH TO BEDSIDE
por: Raychaudhury, Siba P
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_r9658boiuoj60e357n32ftpb5j